Clinical Trial Update: Acetazolamide on REM OSA [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 trial evaluating acetazolamide for REM-related obstructive sleep apnea has been completed under Brigham and Women's Hospital.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obstructive Sleep Apnea

Drugs mentioned

• ACETAZOLAMIDE (acetazolamide)

Snippet

Sponsor: Brigham and Women's Hospital | Conditions: Obstructive Sleep Apnea | Phase 1, Phase 2 | Status: COMPLETED